Perfil
Brian A.
Pryor is the founder of LiteCure LLC, where he currently holds the title of Chief Executive Officer.
He also currently works as a Director at Nanospectra Biosciences, Inc.
Cargos activos de Brian A. Pryor
| Empresas | Cargo | Inicio |
|---|---|---|
LiteCure LLC
 LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE. | Director Ejecutivo | 01/01/2007 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
LiteCure LLC
LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE. | Health Technology |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Brian A. Pryor
